Showing results (11-20 of 365) with videos related to
Sort By:
Pageof 37
Annals of Hepatology|January 8, 2013
Patients younger than forty years old with hepatitis C virus genotype-1 chronic infection had treatment responses similar to genotype-2 infection and not related to interleukin-28B polymorphismChun-Yen Lin, I-Shyan Sheen, Wen-Juei Jeng, et al.Journal of the Formosan Medical Association = Taiwan Yi Zhi|February 3, 2024
Subsequent locoregional therapy prolongs survival in progressive hepatocellular carcinoma patients under lenvatinib treatmentPo-Ting Lin, Wei Teng, Wen-Juei Jeng, et al.Cancer Medicine|April 18, 2022
Soluble form of CTLA-4 is a good predictor for tumor recurrence after radiofrequency ablation in hepatocellular carcinoma patientsWei Teng, Wen-Juei Jeng, Wei-Ting Chen, et al.Viruses|September 28, 2024
Hepatocellular Carcinoma Incidences and Risk Factors in Hepatitis C Patients: Interferon versus Direct-Acting AgentsYu-Ting Kao, Yen-Chun Liu, Ya-Ting Cheng, et al.Virology Journal|April 1, 2022
The association between sPD-1 levels versus liver biochemistry and viral markers in chronic hepatitis B patients: a comparative study of different sPD-1 assaysWen-Juei Jeng, Chien-Hung Chen, Yi-Wen Wang, et al.Plos One|March 20, 2019
In HCV-related liver cirrhosis, local pulse wave velocity increases and in decompensated patients correlates with poorer survivalChien-Hao Huang, Lung-Sheng Wu, Wen-Juei Jeng, et al.Journal of Clinical Gastroenterology|July 12, 2013
Various predictors of sustained virologic response in different age groups of patients with genotype-1 chronic hepatitis CChun-Yen Lin, I-Shyan Sheen, Ji-Yih Chen, et al.Biomedical Journal|January 4, 2017
Percutaneous radiofrequency ablation of tumor feeding artery before target tumor ablation may reduce local tumor progression in hepatocellular carcinomaYa-Ting Cheng, Wen-Juei Jeng, Chen-Chun Lin, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 21, 2020
Should Treatment Indications for Chronic Hepatitis B Be Expanded?Wen-Juei Jeng, Anna S LokSeminars in Liver Disease|June 28, 2021
Finite Antiviral Therapy in Chronic Hepatitis B Patients with CirrhosisWen-Juei Jeng, Yun-Fan LiawPageof 37